THIO Sequenced With Cemiplimab in Advanced NSCLC

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(35 sites)

United States

Central Alabama Research, Birmingham, Alabama

Summit Health, Florham Park, New Jersey

Australia

Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland

Cancer Research SA, Adelaide, South Australia

St. Vincent Hospital Melbourne, Fitzroy, Victoria